Related Experiment Video
Updated: Dec 6, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Relationship between monocyte/lymphocyte ratio and non-culprit plaque vulnerability in patients with acute coronary
Ting-Yu Zhang1, Qi Zhao1, Ze-Sen Liu2
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University.
Insights
The monocyte/lymphocyte ratio (MLR) is linked to vulnerable coronary plaques in acute coronary syndrome patients. Higher MLR indicates increased plaque vulnerability, suggesting its potential as a non-invasive biomarker.
Area of Science:
- Cardiology
- Immunology
- Medical Imaging
Background:
- Monocyte/lymphocyte ratio (MLR) is implicated in coronary artery disease (CAD) development.
- Limited research exists on the association between MLR and coronary plaque vulnerability.
- Acute coronary syndrome (ACS) necessitates understanding plaque instability for risk stratification.
Purpose of the Study:
- To investigate the relationship between MLR and non-culprit plaque vulnerability in ACS patients.
- To assess plaque morphology and vulnerability features using optical coherence tomography (OCT).
- To determine if MLR can predict vulnerable plaque characteristics like thin-cap fibro-atheroma (TCFA).
Main Methods:
- Retrospective analysis of 72 ACS patients undergoing coronary angiography and OCT.
- Assessment of plaque vulnerability and morphology via OCT imaging.
- Statistical analysis including correlation, logistic regression, and diagnostic performance evaluation of MLR.
Main Results:
- Higher MLR group showed more vulnerable plaques: thinner fibrous caps, larger lipid cores, and longer lipid plaque lengths.
- Significant negative correlation between MLR and fibrous cap thickness (R=-0.225, P=.005).
- Increased prevalence of TCFA (P=.014) and plaque rupture (P=.017) in high MLR group; MLR independently predicted TCFA (OR=3.316, P=.005).
Conclusions:
- Circulating MLR is a potential non-invasive biomarker for identifying vulnerable coronary plaques in ACS patients.
- Elevated MLR is associated with specific vulnerable plaque features and independently predicts TCFA.
- MLR may serve as a valuable indicator of inflammation-related plaque vulnerability.
Abstract:
The importance of monocyte/lymphocyte ratio (MLR) has been indicated in the initiation and progression of coronary artery disease. However, few previous researches demonstrated the relationship between MLR and plaque vulnerability. We aimed to investigate coronary non-culprit plaque vulnerability in patients with acute coronary syndrome (ACS) by optical coherence tomography (OCT).A total of 72 ACS patients who underwent coronary angiography and OCT test in Beijing Anzhen Hospital were included in this retrospective study. The plaque vulnerability and plaque morphology were assessed by OCT.The non-culprit plaque in high MLR group exhibited more vulnerable features, characterizing as thinner thickness of fibrous cap (P = .013), greater maximum lipid core angle (P = .010) and longer lipid plaque length (P = .041). A prominently negative liner relation was found between MLR and thickness of fibrous cap (R = -0.225, P = .005). Meanwhile, the proportion of OCT-detected thin cap fibro-atheroma (TCFA) (P = .014) and plaque rupture (P = .017) were higher in high MLR group. Most importantly, multivariable logistic regression analysis showed MLR level was identified as an independent contributor to the presence of TCFA (OR:3.316, 95%: 1.448-7.593, P = .005). MLR could differentiate TCFA with a sensitivity of 60.0% and a specificity of 85.1%.Circulating MLR level has potential value in identifying the presence of vulnerable plaque in patients with ACS. MLR, as a non- invasive biomarker of inflammation, may be valuable in revealing plaque vulnerability.
More Related Videos
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
07:18Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
Published on: February 18, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction